

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.23723570 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.23723570 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.80586862 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.80586862 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.63051317 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.52371391 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.29946056 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.23357436 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.12742507 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.12742507 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.12742507 |
| 12 | protein carboxylation (GO:0018214) | 4.94918975 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94918975 |
| 14 | complement activation, alternative pathway (GO:0006957) | 4.91445934 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.85113186 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.82316549 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.78792386 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.74432010 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.72361559 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.61509395 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59975777 |
| 22 | urea metabolic process (GO:0019627) | 4.58879486 |
| 23 | urea cycle (GO:0000050) | 4.58879486 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.58743045 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.56688633 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.56688633 |
| 27 | cysteine metabolic process (GO:0006534) | 4.53458178 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.45824019 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 4.45824019 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 4.45824019 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 4.45824019 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.45824019 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.45824019 |
| 34 | response to peptidoglycan (GO:0032494) | 4.44364174 |
| 35 | regulation of complement activation (GO:0030449) | 4.42961886 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38525382 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.36847452 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.34877454 |
| 39 | bile acid metabolic process (GO:0008206) | 4.29763864 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26560294 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.24112743 |
| 42 | aldehyde catabolic process (GO:0046185) | 4.22554692 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.19321901 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.15963498 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.13890215 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.13512505 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12312802 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 4.08634071 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.06683338 |
| 50 | phospholipid efflux (GO:0033700) | 3.98331740 |
| 51 | amine catabolic process (GO:0009310) | 3.91097480 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 3.91097480 |
| 53 | cholesterol efflux (GO:0033344) | 3.89279524 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.88292930 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87775769 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.86880738 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.86880738 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.86880738 |
| 59 | leukocyte aggregation (GO:0070486) | 3.85862984 |
| 60 | opsonization (GO:0008228) | 3.85632506 |
| 61 | triglyceride homeostasis (GO:0070328) | 3.84761517 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.84761517 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.84142846 |
| 64 | reverse cholesterol transport (GO:0043691) | 3.79735077 |
| 65 | detection of other organism (GO:0098543) | 3.78977654 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.77087806 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.76997816 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.75340397 |
| 69 | detection of bacterium (GO:0016045) | 3.73635354 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 3.71792485 |
| 71 | fibrinolysis (GO:0042730) | 3.68687877 |
| 72 | phospholipid homeostasis (GO:0055091) | 3.68195559 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 3.67138454 |
| 74 | cellular glucuronidation (GO:0052695) | 3.62178245 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.60960288 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.58007608 |
| 77 | cofactor catabolic process (GO:0051187) | 3.56666535 |
| 78 | very long-chain fatty acid metabolic process (GO:0000038) | 3.53765282 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.51891607 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.48496941 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 3.44954369 |
| 82 | negative regulation of lipase activity (GO:0060192) | 3.44684114 |
| 83 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44460117 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.44331072 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.43491174 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.43491174 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.43283168 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 3.42492135 |
| 89 | cellular response to ethanol (GO:0071361) | 3.42422065 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.39590559 |
| 91 | imidazole-containing compound metabolic process (GO:0052803) | 3.38795455 |
| 92 | bile acid and bile salt transport (GO:0015721) | 3.38286854 |
| 93 | benzene-containing compound metabolic process (GO:0042537) | 3.37302869 |
| 94 | urate metabolic process (GO:0046415) | 3.37185813 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35838013 |
| 96 | granulocyte activation (GO:0036230) | 3.33482960 |
| 97 | neutrophil activation (GO:0042119) | 3.32341651 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 3.31434464 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.31239182 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.31163399 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.31163399 |
| 102 | cytolysis (GO:0019835) | 3.30347343 |
| 103 | glutamate metabolic process (GO:0006536) | 3.29877358 |
| 104 | detection of external biotic stimulus (GO:0098581) | 3.29628805 |
| 105 | response to muramyl dipeptide (GO:0032495) | 3.29349943 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.28403226 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.27965896 |
| 108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.27734643 |
| 109 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.27734643 |
| 110 | NAD biosynthetic process (GO:0009435) | 3.27712086 |
| 111 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.26974034 |
| 112 | regulation of cholesterol metabolic process (GO:0090181) | 3.26539019 |
| 113 | fatty acid oxidation (GO:0019395) | 3.25058672 |
| 114 | sterol homeostasis (GO:0055092) | 3.24639556 |
| 115 | complement activation (GO:0006956) | 3.23794518 |
| 116 | lysine metabolic process (GO:0006553) | 3.22630501 |
| 117 | lysine catabolic process (GO:0006554) | 3.22630501 |
| 118 | fatty acid beta-oxidation (GO:0006635) | 3.21983583 |
| 119 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.21382930 |
| 120 | fatty acid catabolic process (GO:0009062) | 3.20382616 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 3.19809919 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.19762711 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.19594792 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.18971388 |
| 125 | lipid oxidation (GO:0034440) | 3.18702001 |
| 126 | glycine metabolic process (GO:0006544) | 3.17881812 |
| 127 | fatty acid elongation (GO:0030497) | 3.16474974 |
| 128 | low-density lipoprotein particle remodeling (GO:0034374) | 3.15517302 |
| 129 | protein activation cascade (GO:0072376) | 3.15360720 |
| 130 | cellular ketone body metabolic process (GO:0046950) | 3.14618725 |
| 131 | detection of molecule of bacterial origin (GO:0032490) | 3.14429238 |
| 132 | monocarboxylic acid catabolic process (GO:0072329) | 3.14265551 |
| 133 | type I interferon signaling pathway (GO:0060337) | 3.12647722 |
| 134 | cellular response to type I interferon (GO:0071357) | 3.12647722 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12332408 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08936331 |
| 137 | response to type I interferon (GO:0034340) | 3.08888215 |
| 138 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08347205 |
| 139 | germinal center formation (GO:0002467) | 3.05705768 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04623844 |
| 141 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02000241 |
| 142 | response to host immune response (GO:0052572) | 3.02000241 |
| 143 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00256704 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 2.97543243 |
| 145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96305136 |
| 146 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.92354881 |
| 147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92117227 |
| 148 | response to host (GO:0075136) | 2.92117227 |
| 149 | response to host defenses (GO:0052200) | 2.92117227 |
| 150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89365610 |
| 151 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87716945 |
| 152 | mannose metabolic process (GO:0006013) | 2.87050417 |
| 153 | cellular extravasation (GO:0045123) | 2.86140750 |
| 154 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84097338 |
| 155 | detection of biotic stimulus (GO:0009595) | 2.83187307 |
| 156 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.79881930 |
| 157 | respiratory burst (GO:0045730) | 2.79528894 |
| 158 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77786871 |
| 159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75673565 |
| 160 | regulation of T cell tolerance induction (GO:0002664) | 2.75086509 |
| 161 | myeloid dendritic cell differentiation (GO:0043011) | 2.74544504 |
| 162 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74295352 |
| 163 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71385805 |
| 164 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70280277 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.69094631 |
| 166 | positive thymic T cell selection (GO:0045059) | 2.68996538 |
| 167 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67837379 |
| 168 | B cell mediated immunity (GO:0019724) | 2.67053955 |
| 169 | protein localization to endosome (GO:0036010) | 2.66612771 |
| 170 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66342020 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63846138 |
| 172 | positive regulation of mast cell activation (GO:0033005) | 2.62307653 |
| 173 | macrophage activation (GO:0042116) | 2.60210226 |
| 174 | defense response to protozoan (GO:0042832) | 2.60179036 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.59367057 |
| 176 | negative regulation of innate immune response (GO:0045824) | 2.58268170 |
| 177 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.57761155 |
| 178 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.57761155 |
| 179 | modulation by symbiont of host cellular process (GO:0044068) | 2.57344411 |
| 180 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57093917 |
| 181 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.56902894 |
| 182 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55553295 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.55025678 |
| 184 | regulation of type 2 immune response (GO:0002828) | 2.54545270 |
| 185 | pinocytosis (GO:0006907) | 2.52983204 |
| 186 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52744676 |
| 187 | leukocyte degranulation (GO:0043299) | 2.51738845 |
| 188 | myeloid dendritic cell activation (GO:0001773) | 2.50885932 |
| 189 | regulation of superoxide anion generation (GO:0032928) | 2.50711125 |
| 190 | regulation of mast cell activation (GO:0033003) | 2.48887185 |
| 191 | regulation of defense response to virus by virus (GO:0050690) | 2.46705717 |
| 192 | response to protozoan (GO:0001562) | 2.45831271 |
| 193 | response to interleukin-15 (GO:0070672) | 2.44713286 |
| 194 | regulation of tolerance induction (GO:0002643) | 2.44265760 |
| 195 | thymic T cell selection (GO:0045061) | 2.43260582 |
| 196 | negative regulation of interleukin-6 production (GO:0032715) | 2.42558863 |
| 197 | T cell migration (GO:0072678) | 2.42400660 |
| 198 | positive regulation of type 2 immune response (GO:0002830) | 2.42090691 |
| 199 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.40545341 |
| 200 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40541230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.43844383 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.59909816 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.42519239 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.81088817 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41165493 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.52994996 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.18226919 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75312515 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51805380 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.31708936 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.27703979 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.91705396 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60003545 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.50723900 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36230569 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.36218707 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32583318 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30632518 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29087019 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18577718 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17639912 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14852140 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13723848 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.08253343 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03170784 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01307641 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99508820 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96042324 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92253573 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90211343 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90164847 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89381207 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87790895 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86133816 |
| 35 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85400573 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85222583 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84592295 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.78612118 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78225286 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73179663 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70943279 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70369525 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.69749761 |
| 44 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65925902 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63435265 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59909993 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57957342 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57616409 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57547426 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55285709 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53653680 |
| 52 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53002993 |
| 53 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53002993 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50196892 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49877245 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49723697 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46906880 |
| 58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46334256 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45933859 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43493094 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42021352 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41321228 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40858467 |
| 64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39689718 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39274354 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39076000 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37650807 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35746776 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34768489 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.33652953 |
| 71 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33508689 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32850588 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32725273 |
| 74 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31810835 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31683381 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31017445 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.30779296 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.28346998 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28164547 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27767364 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27367987 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27331085 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26226912 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25354904 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24582380 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24386988 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.23285144 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23269013 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22794056 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18259708 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18214263 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17666678 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17654101 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17286252 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15565257 |
| 96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15060101 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15001330 |
| 98 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13915298 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12768611 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08960233 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07828478 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07398091 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06356225 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06146740 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04740012 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02832020 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02178681 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01061322 |
| 109 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00909884 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00469756 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00358073 |
| 112 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00059066 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95145937 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95125880 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92291173 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90065333 |
| 117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89477478 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89454758 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89241062 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88870377 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85793741 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84589363 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84475855 |
| 124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84380960 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82413289 |
| 126 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80670253 |
| 127 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80550502 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78977473 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77807351 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77599718 |
| 131 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77014132 |
| 132 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74865444 |
| 133 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74257755 |
| 134 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.73775643 |
| 135 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.73739357 |
| 136 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73150919 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72808425 |
| 138 | TP53_16413492_ChIP-PET_HCT116_Human | 0.72637394 |
| 139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70767293 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70289539 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69589113 |
| 142 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68421806 |
| 143 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66975020 |
| 144 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.66603227 |
| 145 | GATA3_26560356_Chip-Seq_TH2_Human | 0.64582816 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62729298 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62003059 |
| 148 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.60425320 |
| 149 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60414973 |
| 150 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.59926804 |
| 151 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.59685127 |
| 152 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59233045 |
| 153 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58705481 |
| 154 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.57700436 |
| 155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57143619 |
| 156 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.56429539 |
| 157 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.55829450 |
| 158 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.55382709 |
| 159 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54908831 |
| 160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54799369 |
| 161 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.54595885 |
| 162 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.54495651 |
| 163 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.54495651 |
| 164 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.54421872 |
| 165 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.54267860 |
| 166 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53040935 |
| 167 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.49197811 |
| 168 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.49057302 |
| 169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.48626978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.84947691 |
| 2 | MP0005360_urolithiasis | 5.93435568 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.72559873 |
| 4 | MP0005365_abnormal_bile_salt | 4.93761861 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.95286262 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.78269625 |
| 7 | MP0003303_peritoneal_inflammation | 3.71318603 |
| 8 | MP0003252_abnormal_bile_duct | 3.52502375 |
| 9 | MP0003195_calcinosis | 3.50527744 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.15761150 |
| 11 | MP0009840_abnormal_foam_cell | 2.91713672 |
| 12 | MP0005083_abnormal_biliary_tract | 2.70294869 |
| 13 | MP0008260_abnormal_autophagy | 2.45652947 |
| 14 | MP0005671_abnormal_response_to | 2.42890016 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.38879159 |
| 16 | MP0005332_abnormal_amino_acid | 2.35468137 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.32638825 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.19490858 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.03137054 |
| 20 | * MP0001819_abnormal_immune_cell | 2.01746817 |
| 21 | MP0000858_altered_metastatic_potential | 1.99519073 |
| 22 | MP0003868_abnormal_feces_composition | 1.91721508 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.91066460 |
| 24 | MP0009278_abnormal_bone_marrow | 1.90879019 |
| 25 | * MP0000609_abnormal_liver_physiology | 1.89786044 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.88128573 |
| 27 | MP0005408_hypopigmentation | 1.85856736 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.85103617 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.82183586 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.79618603 |
| 31 | MP0003690_abnormal_glial_cell | 1.71803848 |
| 32 | MP0000604_amyloidosis | 1.68945187 |
| 33 | MP0003186_abnormal_redox_activity | 1.66311743 |
| 34 | MP0003724_increased_susceptibility_to | 1.62869934 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.61368469 |
| 36 | MP0002405_respiratory_system_inflammati | 1.60691065 |
| 37 | MP0005451_abnormal_body_composition | 1.59574159 |
| 38 | MP0004381_abnormal_hair_follicle | 1.58699615 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.56707484 |
| 40 | * MP0000716_abnormal_immune_system | 1.54746443 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.53264228 |
| 42 | * MP0005319_abnormal_enzyme/_coenzyme | 1.46129723 |
| 43 | * MP0009764_decreased_sensitivity_to | 1.45376493 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.42129522 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.41955413 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.41227924 |
| 47 | MP0009697_abnormal_copulation | 1.41198999 |
| 48 | MP0003436_decreased_susceptibility_to | 1.35321911 |
| 49 | MP0001764_abnormal_homeostasis | 1.34813880 |
| 50 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.34607446 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.33722531 |
| 52 | * MP0002429_abnormal_blood_cell | 1.33639460 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.33074032 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.33074032 |
| 55 | * MP0002722_abnormal_immune_system | 1.32088356 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.30746329 |
| 57 | MP0003828_pulmonary_edema | 1.29567053 |
| 58 | * MP0000689_abnormal_spleen_morphology | 1.28942607 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.22764795 |
| 60 | MP0008004_abnormal_stomach_pH | 1.20552606 |
| 61 | MP0004130_abnormal_muscle_cell | 1.19237004 |
| 62 | MP0001851_eye_inflammation | 1.18881417 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.18711823 |
| 64 | MP0002132_abnormal_respiratory_system | 1.18483118 |
| 65 | * MP0009763_increased_sensitivity_to | 1.18062465 |
| 66 | MP0002419_abnormal_innate_immunity | 1.17122144 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.17047490 |
| 68 | MP0006082_CNS_inflammation | 1.16215505 |
| 69 | * MP0008469_abnormal_protein_level | 1.15872224 |
| 70 | MP0002254_reproductive_system_inflammat | 1.13992286 |
| 71 | MP0003448_altered_tumor_morphology | 1.12660284 |
| 72 | MP0009785_altered_susceptibility_to | 1.12149192 |
| 73 | MP0001873_stomach_inflammation | 1.11872388 |
| 74 | * MP0000598_abnormal_liver_morphology | 1.08424562 |
| 75 | MP0000920_abnormal_myelination | 1.06800691 |
| 76 | * MP0000703_abnormal_thymus_morphology | 1.06170868 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.04135702 |
| 78 | MP0003329_amyloid_beta_deposits | 1.04022240 |
| 79 | MP0003091_abnormal_cell_migration | 1.03956298 |
| 80 | MP0003866_abnormal_defecation | 1.03753072 |
| 81 | MP0003011_delayed_dark_adaptation | 1.02413781 |
| 82 | MP0005166_decreased_susceptibility_to | 1.00984475 |
| 83 | MP0005164_abnormal_response_to | 1.00401510 |
| 84 | MP0000490_abnormal_crypts_of | 0.99478377 |
| 85 | MP0001849_ear_inflammation | 0.97697798 |
| 86 | * MP0009765_abnormal_xenobiotic_induced | 0.96620591 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.95682809 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.95450689 |
| 89 | MP0005390_skeleton_phenotype | 0.94774182 |
| 90 | MP0004510_myositis | 0.94629206 |
| 91 | MP0005025_abnormal_response_to | 0.93883725 |
| 92 | MP0004883_abnormal_blood_vessel | 0.93217378 |
| 93 | MP0003279_aneurysm | 0.90213163 |
| 94 | MP0005023_abnormal_wound_healing | 0.89224661 |
| 95 | MP0002796_impaired_skin_barrier | 0.88742957 |
| 96 | MP0001663_abnormal_digestive_system | 0.88174921 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.86416209 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.85144664 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.84468624 |
| 100 | MP0002933_joint_inflammation | 0.82540244 |
| 101 | MP0003795_abnormal_bone_structure | 0.80458228 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.80323226 |
| 103 | MP0000249_abnormal_blood_vessel | 0.79797861 |
| 104 | MP0002148_abnormal_hypersensitivity_rea | 0.79571835 |
| 105 | MP0001790_abnormal_immune_system | 0.78037683 |
| 106 | MP0005387_immune_system_phenotype | 0.78037683 |
| 107 | * MP0009642_abnormal_blood_homeostasis | 0.76778791 |
| 108 | * MP0001845_abnormal_inflammatory_respons | 0.76567715 |
| 109 | * MP0008874_decreased_physiological_sensi | 0.76348851 |
| 110 | * MP0001800_abnormal_humoral_immune | 0.75423538 |
| 111 | MP0002168_other_aberrant_phenotype | 0.75226768 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.74987175 |
| 113 | MP0001958_emphysema | 0.74098092 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.73691657 |
| 115 | MP0001853_heart_inflammation | 0.71388541 |
| 116 | MP0005395_other_phenotype | 0.71382397 |
| 117 | MP0005647_abnormal_sex_gland | 0.68965042 |
| 118 | MP0009379_abnormal_foot_pigmentation | 0.68057167 |
| 119 | * MP0003453_abnormal_keratinocyte_physiol | 0.67829241 |
| 120 | * MP0004947_skin_inflammation | 0.67584904 |
| 121 | MP0003705_abnormal_hypodermis_morpholog | 0.67338456 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.67061674 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.65741758 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.64899003 |
| 125 | MP0005171_absent_coat_pigmentation | 0.64688587 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.64561303 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.64550837 |
| 128 | MP0005334_abnormal_fat_pad | 0.64408437 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.64108309 |
| 130 | MP0001661_extended_life_span | 0.61946907 |
| 131 | MP0002928_abnormal_bile_duct | 0.60574464 |
| 132 | MP0004858_abnormal_nervous_system | 0.60536108 |
| 133 | * MP0008873_increased_physiological_sensi | 0.60246880 |
| 134 | * MP0002723_abnormal_immune_serum | 0.60159231 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.59052116 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.58112266 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.55759117 |
| 138 | MP0002060_abnormal_skin_morphology | 0.55073527 |
| 139 | MP0005275_abnormal_skin_tensile | 0.54959938 |
| 140 | * MP0002078_abnormal_glucose_homeostasis | 0.54525646 |
| 141 | MP0002971_abnormal_brown_adipose | 0.54107318 |
| 142 | MP0001243_abnormal_dermal_layer | 0.53277612 |
| 143 | MP0003075_altered_response_to | 0.51548539 |
| 144 | MP0000685_abnormal_immune_system | 0.51504424 |
| 145 | MP0000343_altered_response_to | 0.50324823 |
| 146 | MP0001542_abnormal_bone_strength | 0.49719460 |
| 147 | MP0005310_abnormal_salivary_gland | 0.49693140 |
| 148 | MP0002090_abnormal_vision | 0.49001622 |
| 149 | MP0006036_abnormal_mitochondrial_physio | 0.47917696 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.47771470 |
| 151 | MP0005666_abnormal_adipose_tissue | 0.47113268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.88391771 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.81622719 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.74737261 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.68196138 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61582169 |
| 6 | Xanthomatosis (HP:0000991) | 5.52611899 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.99805731 |
| 8 | Complement deficiency (HP:0004431) | 4.99707990 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.94610396 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.85519390 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.84101070 |
| 12 | Joint hemorrhage (HP:0005261) | 4.46482042 |
| 13 | Abnormality of complement system (HP:0005339) | 3.97254610 |
| 14 | Epidermoid cyst (HP:0200040) | 3.83745076 |
| 15 | Myositis (HP:0100614) | 3.75384781 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.70424579 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.69243336 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66288978 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.64233003 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.64233003 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.64233003 |
| 22 | Hyperammonemia (HP:0001987) | 3.60829964 |
| 23 | Fat malabsorption (HP:0002630) | 3.60339887 |
| 24 | Petechiae (HP:0000967) | 3.57995959 |
| 25 | Orchitis (HP:0100796) | 3.57425654 |
| 26 | Myocardial infarction (HP:0001658) | 3.54928647 |
| 27 | Hyperglycinemia (HP:0002154) | 3.54470623 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.53744777 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48199954 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.44456362 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43143817 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.37949456 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.37949456 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.34565411 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34289229 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.32856708 |
| 37 | Obstructive lung disease (HP:0006536) | 3.32856708 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32833735 |
| 39 | Hyperglycinuria (HP:0003108) | 3.32567207 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30738611 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.30449735 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 3.23226156 |
| 43 | Dysostosis multiplex (HP:0000943) | 3.18277593 |
| 44 | Epistaxis (HP:0000421) | 3.17531736 |
| 45 | Hypoglycemic coma (HP:0001325) | 3.16770973 |
| 46 | Optic neuritis (HP:0100653) | 3.12645406 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 3.12645406 |
| 48 | Hypercholesterolemia (HP:0003124) | 3.09626142 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07933794 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 3.04921058 |
| 51 | Stomatitis (HP:0010280) | 3.02190401 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.99070411 |
| 53 | Steatorrhea (HP:0002570) | 2.93140810 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.92824706 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.91250825 |
| 56 | Spontaneous abortion (HP:0005268) | 2.90064006 |
| 57 | Ketosis (HP:0001946) | 2.84687972 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.84555840 |
| 59 | Gingival bleeding (HP:0000225) | 2.81089593 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.80501806 |
| 61 | Mitral stenosis (HP:0001718) | 2.79848759 |
| 62 | Glomerulonephritis (HP:0000099) | 2.78188703 |
| 63 | Meningitis (HP:0001287) | 2.77681928 |
| 64 | Amyloidosis (HP:0011034) | 2.76783388 |
| 65 | Cellulitis (HP:0100658) | 2.76655951 |
| 66 | Skin nodule (HP:0200036) | 2.74072404 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.73965417 |
| 68 | Abnormal cartilage morphology (HP:0002763) | 2.72344276 |
| 69 | Increased IgE level (HP:0003212) | 2.71500637 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.70198207 |
| 71 | Loss of speech (HP:0002371) | 2.68951013 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.63304885 |
| 73 | Gingivitis (HP:0000230) | 2.62081499 |
| 74 | * Hemorrhage of the eye (HP:0011885) | 2.60998111 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60270514 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60270514 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60270514 |
| 78 | Recurrent skin infections (HP:0001581) | 2.54204232 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49128854 |
| 80 | Mucopolysacchariduria (HP:0008155) | 2.49128854 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.48127674 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.47290931 |
| 83 | Vasculitis (HP:0002633) | 2.46417460 |
| 84 | Increased mean platelet volume (HP:0011877) | 2.46296426 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.44271682 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43382513 |
| 87 | Urticaria (HP:0001025) | 2.40427935 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.35876480 |
| 89 | Pustule (HP:0200039) | 2.32656910 |
| 90 | Delayed CNS myelination (HP:0002188) | 2.30818280 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.23947996 |
| 92 | Abnormal platelet function (HP:0011869) | 2.23409737 |
| 93 | Impaired platelet aggregation (HP:0003540) | 2.23409737 |
| 94 | Vertebral compression fractures (HP:0002953) | 2.22341680 |
| 95 | Episodic fever (HP:0001954) | 2.22187215 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.21166783 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 2.20203669 |
| 98 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19345538 |
| 99 | Recurrent viral infections (HP:0004429) | 2.19314694 |
| 100 | Esophageal varix (HP:0002040) | 2.18372620 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 2.17751431 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.16815250 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.16633504 |
| 104 | Nephritis (HP:0000123) | 2.15838723 |
| 105 | Vascular calcification (HP:0004934) | 2.14318583 |
| 106 | Inflammation of the large intestine (HP:0002037) | 2.13966606 |
| 107 | Hypertensive crisis (HP:0100735) | 2.13700117 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09224595 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.08271657 |
| 110 | Ketoacidosis (HP:0001993) | 2.07480839 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.07334535 |
| 112 | * Encephalitis (HP:0002383) | 2.07295701 |
| 113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06738591 |
| 114 | Fatigue (HP:0012378) | 2.05491718 |
| 115 | Lethargy (HP:0001254) | 2.04232686 |
| 116 | Renal cortical cysts (HP:0000803) | 2.03984312 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03980564 |
| 118 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03980564 |
| 119 | Arterial thrombosis (HP:0004420) | 2.03108983 |
| 120 | Chest pain (HP:0100749) | 2.02550122 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 2.02313020 |
| 122 | Thrombophlebitis (HP:0004418) | 2.02055395 |
| 123 | Colitis (HP:0002583) | 2.02024871 |
| 124 | Anorexia (HP:0002039) | 2.00833959 |
| 125 | Pancreatitis (HP:0001733) | 2.00831651 |
| 126 | Cardiovascular calcification (HP:0011915) | 2.00622953 |
| 127 | Distal lower limb amyotrophy (HP:0008944) | 1.99172091 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.98464047 |
| 129 | Cholelithiasis (HP:0001081) | 1.97472127 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.97365865 |
| 131 | Axonal loss (HP:0003447) | 1.97078725 |
| 132 | Opisthotonus (HP:0002179) | 1.96667851 |
| 133 | Abnormality of macrophages (HP:0004311) | 1.96533095 |
| 134 | Polycythemia (HP:0001901) | 1.96468871 |
| 135 | Nausea (HP:0002018) | 1.96435722 |
| 136 | Hemoptysis (HP:0002105) | 1.95641918 |
| 137 | Increased serum ferritin (HP:0003281) | 1.95263555 |
| 138 | Purpura (HP:0000979) | 1.95118141 |
| 139 | Rickets (HP:0002748) | 1.94570081 |
| 140 | Glomerulopathy (HP:0100820) | 1.94351006 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.93598740 |
| 142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93598740 |
| 143 | Spastic diplegia (HP:0001264) | 1.93582510 |
| 144 | Abnormality of the Achilles tendon (HP:0005109) | 1.92472500 |
| 145 | Acanthocytosis (HP:0001927) | 1.91945449 |
| 146 | Pulmonary embolism (HP:0002204) | 1.91382185 |
| 147 | Keratoconjunctivitis (HP:0001096) | 1.89990298 |
| 148 | Progressive neurologic deterioration (HP:0002344) | 1.89465719 |
| 149 | Vacuolated lymphocytes (HP:0001922) | 1.88473581 |
| 150 | Fair hair (HP:0002286) | 1.88431642 |
| 151 | Metabolic acidosis (HP:0001942) | 1.87785815 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.87711468 |
| 153 | Cerebral hemorrhage (HP:0001342) | 1.84312152 |
| 154 | Achilles tendon contracture (HP:0001771) | 1.84205354 |
| 155 | Spastic paraparesis (HP:0002313) | 1.84134709 |
| 156 | Increased connective tissue (HP:0009025) | 1.83395548 |
| 157 | Hydroxyprolinuria (HP:0003080) | 1.82592788 |
| 158 | Abnormality of proline metabolism (HP:0010907) | 1.82592788 |
| 159 | Osteomyelitis (HP:0002754) | 1.81783793 |
| 160 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81544578 |
| 161 | Hypochromic anemia (HP:0001931) | 1.80361589 |
| 162 | Cholecystitis (HP:0001082) | 1.79911005 |
| 163 | Abnormal gallbladder physiology (HP:0012438) | 1.79911005 |
| 164 | Slow saccadic eye movements (HP:0000514) | 1.79570862 |
| 165 | Recurrent bacterial skin infections (HP:0005406) | 1.79563081 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79525802 |
| 167 | T lymphocytopenia (HP:0005403) | 1.79208445 |
| 168 | Distal lower limb muscle weakness (HP:0009053) | 1.79131871 |
| 169 | Menorrhagia (HP:0000132) | 1.79017379 |
| 170 | Joint swelling (HP:0001386) | 1.78574551 |
| 171 | Gastrointestinal stroma tumor (HP:0100723) | 1.77998467 |
| 172 | Irritability (HP:0000737) | 1.77590169 |
| 173 | Progressive external ophthalmoplegia (HP:0000590) | 1.74810627 |
| 174 | Erythroderma (HP:0001019) | 1.73594466 |
| 175 | Elevated alkaline phosphatase (HP:0003155) | 1.73454507 |
| 176 | Hypertriglyceridemia (HP:0002155) | 1.73023625 |
| 177 | Neurofibrillary tangles (HP:0002185) | 1.71910474 |
| 178 | Peritonitis (HP:0002586) | 1.71864593 |
| 179 | Recurrent abscess formation (HP:0002722) | 1.70859809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.75292991 |
| 2 | IRAK4 | 3.60233181 |
| 3 | EPHB1 | 3.04094687 |
| 4 | TRIB3 | 2.72785617 |
| 5 | MAP2K3 | 2.65421227 |
| 6 | SIK1 | 2.57652028 |
| 7 | FLT3 | 2.55581427 |
| 8 | MST4 | 2.49285922 |
| 9 | BCKDK | 2.41567567 |
| 10 | TNIK | 2.17786544 |
| 11 | MAP3K14 | 2.17628002 |
| 12 | IRAK2 | 2.12273678 |
| 13 | FGFR4 | 2.12180488 |
| 14 | TAOK2 | 2.04466085 |
| 15 | PKN2 | 1.99949174 |
| 16 | ZAP70 | 1.98930246 |
| 17 | ABL2 | 1.95811260 |
| 18 | MAP3K11 | 1.94167404 |
| 19 | NEK9 | 1.93048685 |
| 20 | PBK | 1.90250946 |
| 21 | IRAK1 | 1.82149247 |
| 22 | GRK6 | 1.81654529 |
| 23 | TESK2 | 1.81203729 |
| 24 | TAOK1 | 1.67689567 |
| 25 | SMG1 | 1.67254560 |
| 26 | PKN1 | 1.63522387 |
| 27 | TAOK3 | 1.63035891 |
| 28 | FES | 1.52682711 |
| 29 | SIK3 | 1.51915250 |
| 30 | ERBB4 | 1.50242404 |
| 31 | ZAK | 1.48045734 |
| 32 | TYK2 | 1.47299027 |
| 33 | MAP3K13 | 1.47192368 |
| 34 | CSF1R | 1.45157485 |
| 35 | INSRR | 1.44358828 |
| 36 | JAK1 | 1.41399775 |
| 37 | BTK | 1.38139473 |
| 38 | MST1R | 1.37926837 |
| 39 | TBK1 | 1.36620162 |
| 40 | CAMKK2 | 1.33357059 |
| 41 | TNK2 | 1.31858764 |
| 42 | ERN1 | 1.30837700 |
| 43 | CSK | 1.28967977 |
| 44 | FRK | 1.24017731 |
| 45 | TESK1 | 1.21878453 |
| 46 | BMX | 1.20370023 |
| 47 | MAP3K1 | 1.18392888 |
| 48 | PIK3CG | 1.17314737 |
| 49 | BCR | 1.13634814 |
| 50 | IKBKE | 1.12639064 |
| 51 | STK39 | 1.09846095 |
| 52 | MARK3 | 1.09324152 |
| 53 | STK4 | 1.06645898 |
| 54 | SIK2 | 1.06319672 |
| 55 | * IKBKB | 1.05820757 |
| 56 | MET | 1.05056206 |
| 57 | RIPK1 | 1.04935052 |
| 58 | ICK | 1.04189280 |
| 59 | STK10 | 1.03753786 |
| 60 | PRKD2 | 1.01982655 |
| 61 | ARAF | 1.01317022 |
| 62 | KSR2 | 0.98471817 |
| 63 | BLK | 0.98331597 |
| 64 | GRK7 | 0.96154903 |
| 65 | PIM2 | 0.96025204 |
| 66 | PAK4 | 0.94670373 |
| 67 | MARK1 | 0.93052940 |
| 68 | CDC42BPA | 0.93032202 |
| 69 | EPHA2 | 0.93018062 |
| 70 | EIF2AK3 | 0.90803253 |
| 71 | MARK2 | 0.88229665 |
| 72 | MAP3K3 | 0.86926137 |
| 73 | BRSK2 | 0.85867505 |
| 74 | KIT | 0.85170558 |
| 75 | MATK | 0.84983487 |
| 76 | TGFBR2 | 0.84484028 |
| 77 | JAK2 | 0.82264477 |
| 78 | EIF2AK1 | 0.80810170 |
| 79 | STK16 | 0.79145760 |
| 80 | CLK1 | 0.77756906 |
| 81 | PTK6 | 0.77633902 |
| 82 | BMPR2 | 0.77318213 |
| 83 | PRKCQ | 0.75154122 |
| 84 | EPHA3 | 0.74760935 |
| 85 | EIF2AK2 | 0.71345454 |
| 86 | LYN | 0.70978971 |
| 87 | TTN | 0.70773414 |
| 88 | RIPK4 | 0.70067323 |
| 89 | PLK4 | 0.65969965 |
| 90 | FGFR2 | 0.65844361 |
| 91 | MAP3K6 | 0.65582857 |
| 92 | ABL1 | 0.64275648 |
| 93 | ROCK2 | 0.64201218 |
| 94 | HCK | 0.61240322 |
| 95 | MOS | 0.60430608 |
| 96 | PDPK1 | 0.60301316 |
| 97 | NUAK1 | 0.60114008 |
| 98 | HIPK2 | 0.59478462 |
| 99 | JAK3 | 0.59053022 |
| 100 | NME2 | 0.57945481 |
| 101 | RPS6KA2 | 0.57810363 |
| 102 | GRK1 | 0.57284999 |
| 103 | MAPK4 | 0.56848599 |
| 104 | TXK | 0.56613880 |
| 105 | KDR | 0.56440257 |
| 106 | MAPK11 | 0.56374751 |
| 107 | RPS6KC1 | 0.56212701 |
| 108 | RPS6KL1 | 0.56212701 |
| 109 | CDK12 | 0.55782487 |
| 110 | ITK | 0.54858076 |
| 111 | MAPK12 | 0.54639069 |
| 112 | CAMK2G | 0.53833566 |
| 113 | LRRK2 | 0.53769968 |
| 114 | MAP3K8 | 0.52167240 |
| 115 | PRPF4B | 0.51723999 |
| 116 | MAP3K5 | 0.50778292 |
| 117 | PTK2B | 0.50728463 |
| 118 | CSNK1A1L | 0.50236962 |
| 119 | STK3 | 0.48953987 |
| 120 | OXSR1 | 0.48026868 |
| 121 | CAMK2B | 0.47715999 |
| 122 | SCYL2 | 0.47557866 |
| 123 | DYRK1B | 0.46806438 |
| 124 | CASK | 0.45894135 |
| 125 | MAP3K2 | 0.45700900 |
| 126 | MAPKAPK2 | 0.45668641 |
| 127 | PAK1 | 0.44550558 |
| 128 | CDK4 | 0.44255206 |
| 129 | INSR | 0.43831163 |
| 130 | LCK | 0.43730904 |
| 131 | SYK | 0.43637299 |
| 132 | RET | 0.43511188 |
| 133 | BUB1 | 0.43318138 |
| 134 | CHUK | 0.42734977 |
| 135 | PIM1 | 0.42718312 |
| 136 | ROCK1 | 0.42289038 |
| 137 | NLK | 0.42283955 |
| 138 | PRKG2 | 0.41936705 |
| 139 | PAK3 | 0.41535363 |
| 140 | DDR2 | 0.41493375 |
| 141 | MAPK7 | 0.41352379 |
| 142 | FYN | 0.40927217 |
| 143 | PRKCD | 0.40716702 |
| 144 | BRAF | 0.40333369 |
| 145 | FGR | 0.39959562 |
| 146 | MAP2K2 | 0.39215175 |
| 147 | RPS6KA6 | 0.38303560 |
| 148 | CAMK2D | 0.38009442 |
| 149 | MAP4K1 | 0.37886586 |
| 150 | PRKACG | 0.37803009 |
| 151 | CSNK1G3 | 0.37766039 |
| 152 | ILK | 0.37550650 |
| 153 | MAPKAPK3 | 0.36976504 |
| 154 | PRKCH | 0.36903350 |
| 155 | CDK6 | 0.36525030 |
| 156 | PRKAA2 | 0.36295719 |
| 157 | EGFR | 0.35036833 |
| 158 | STK38 | 0.34465035 |
| 159 | PDK1 | 0.34428768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33016617 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89519650 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.88520749 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88284546 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88088296 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68662027 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68256502 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59302115 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57350580 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56296918 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50990269 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50794468 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49223137 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42552331 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37552002 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.32994516 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20594969 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.19392254 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05269683 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99416860 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.97505423 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97248687 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97211966 |
| 24 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97181821 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95959789 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94753600 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94269252 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93662620 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88420331 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88087779 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.86178872 |
| 32 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70639463 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69966328 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69312848 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.67694094 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65092501 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61266190 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57752312 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54645963 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52665494 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51128592 |
| 42 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.50612374 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.50248569 |
| 44 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.50024640 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48016594 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47605552 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45757811 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45752799 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.45399757 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44207986 |
| 51 | * Shigellosis_Homo sapiens_hsa05131 | 1.40420298 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38518667 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37607873 |
| 54 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36457832 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35687940 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.34146381 |
| 57 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32571203 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.30319579 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29173819 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.28671572 |
| 61 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28530195 |
| 62 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26754467 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.23378207 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21206363 |
| 65 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.20866685 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19990301 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 1.18058579 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17816925 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17587748 |
| 70 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17261837 |
| 71 | * Apoptosis_Homo sapiens_hsa04210 | 1.15921818 |
| 72 | * Hepatitis B_Homo sapiens_hsa05161 | 1.15314087 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15151681 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12558923 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11119146 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11066062 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07730559 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07620422 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 1.06865880 |
| 80 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.06432209 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 1.05546885 |
| 82 | Asthma_Homo sapiens_hsa05310 | 1.05001392 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04303824 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03649473 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02437360 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02109081 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 1.01839952 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01652639 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98995284 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93866701 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91826828 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91441263 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91363090 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90819700 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89236163 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89049919 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87604092 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85825951 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83763985 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82391381 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81204870 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77537177 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72757377 |
| 104 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72193953 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71269766 |
| 106 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71160873 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70241772 |
| 108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68872084 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65993626 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63145406 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63035732 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62770332 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62442098 |
| 114 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.62195452 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59942789 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57493977 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55903689 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52895862 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52412737 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52028531 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51750534 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.49728043 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48109037 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47305723 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46303287 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45996996 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45473658 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44043730 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43895267 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43105111 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43003926 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42505100 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42177963 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.41952895 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38419721 |
| 136 | Malaria_Homo sapiens_hsa05144 | 0.37718409 |
| 137 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37278606 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37123082 |
| 139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37030342 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.35319687 |
| 141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35147080 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33605802 |
| 143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31500342 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.30783664 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27817371 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26603361 |
| 147 | Phagosome_Homo sapiens_hsa04145 | 0.25419222 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.24907282 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.23530568 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.23350770 |
| 151 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.22122355 |
| 152 | Protein export_Homo sapiens_hsa03060 | 0.17749113 |
| 153 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16458597 |
| 154 | * Hepatitis C_Homo sapiens_hsa05160 | 0.13610683 |
| 155 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.13509200 |
| 156 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.12938994 |
| 157 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.11753109 |
| 158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11658073 |
| 159 | Leishmaniasis_Homo sapiens_hsa05140 | 0.11355046 |
| 160 | Allograft rejection_Homo sapiens_hsa05330 | 0.09198102 |
| 161 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.08300073 |
| 162 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07211572 |
| 163 | Viral myocarditis_Homo sapiens_hsa05416 | 0.07207159 |
| 164 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.07139956 |
| 165 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05567839 |
| 166 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04166309 |
| 167 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.03819690 |
| 168 | Measles_Homo sapiens_hsa05162 | 0.03408433 |
| 169 | Amoebiasis_Homo sapiens_hsa05146 | 0.03019470 |
| 170 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.03009763 |
| 171 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.02998494 |

